$19M | ||
$3M | ||
$3M | ||
$2M | ||
$2M | ||
$2M |
Buys | $2,211,927 | 2 | 33 |
Sells | $597,262 | 4 | 67 |
NOVO GUILLERMO | Chair of the Board and CEO | 1 | $2.01M | 0 | $0 | $2.01M |
Assis Alessandra Faccin | SVP and GM, Life Sciences | 1 | $201,600 | 0 | $0 | $201,600 |
BONI ERIC N | VP, Finance & Prinpl Acctg Off | 0 | $0 | 1 | $35,210 | $-35,210 |
LAMPKIN ROBIN E. | SVP, Gen Counsel and Secrty. | 0 | $0 | 2 | $79,855 | $-79,855 |
WILLIS J KEVIN | SVP and CFO | 0 | $0 | 1 | $482,198 | $-482,198 |
Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and …
Over the last 12 months, insiders at Ashland Inc. have bought $2.21M and sold $597,262 worth of Ashland Inc. stock.
On average, over the past 5 years, insiders at Ashland Inc. have bought $19.01M and sold $59.46M worth of stock each year.
Highest buying activity among insiders over the last 12 months: NOVO GUILLERMO (Chair of the Board and CEO) — $2.01M. Assis Alessandra Faccin (SVP and GM, Life Sciences) — $201,600.
The last purchase of 3,150 shares for transaction amount of $201,600 was made by Assis Alessandra Faccin (SVP and GM, Life Sciences) on 2025‑01‑31.
2025-01-31 | NOVO GUILLERMO | Chair of the Board and CEO | 31,294 0.0668% | $64.24 | $2.01M | -8.32% | ||
2025-01-31 | Assis Alessandra Faccin | SVP and GM, Life Sciences | 3,150 0.0067% | $64.00 | $201,600 | -8.32% | ||
2024-12-05 | Sale | BONI ERIC N | VP, Finance & Prinpl Acctg Off | 451 0.001% | $78.07 | $35,210 | -16.06% | |
2024-11-19 | Sale | LAMPKIN ROBIN E. | SVP, Gen Counsel and Secrty. | 162 0.0003% | $75.54 | $12,237 | -14.67% | |
2024-11-15 | Sale | LAMPKIN ROBIN E. | SVP, Gen Counsel and Secrty. | 868 0.0018% | $77.90 | $67,617 | -15.19% | |
2024-09-04 | Sale | WILLIS J KEVIN | SVP and CFO | 5,487 0.0112% | $87.88 | $482,198 | -18.00% | |
2024-02-16 | Sale | LAMPKIN ROBIN E. | SVP, Gen Counsel and Secrty. | 844 0.0017% | $92.54 | $78,104 | -3.29% | |
2023-12-07 | Sale | BONI ERIC N | Principal Accounting Officer | 843 0.0016% | $82.38 | $69,446 | +8.84% | |
2023-09-05 | Sale | WILLIS J KEVIN | Sr.VP &Chief Financial Officer | 7,866 0.0155% | $86.54 | $680,724 | +7.00% | |
2022-09-01 | Sale | Sandler Ricky C | See Remarks | 224,156 0.415% | $100.20 | $22.46M | -0.46% | |
2022-09-01 | Sale | EMINENCE CAPITAL, LP | 224,156 0.415% | $100.20 | $22.46M | -0.46% | ||
2022-09-01 | Sandler Ricky C | See Remarks | 224,156 0.415% | $100.20 | $22.46M | -0.46% | ||
2022-09-01 | EMINENCE CAPITAL, LP | 224,156 0.415% | $100.20 | $22.46M | -0.46% | |||
2022-06-08 | Sale | BONI ERIC N | Principal Accounting Officer | 2,657 0.0049% | $109.50 | $290,942 | -5.30% | |
2022-06-07 | Sale | BONI ERIC N | Principal Accounting Officer | 2,657 0.0049% | $109.50 | $290,942 | -6.83% | |
2022-06-02 | Sale | WILLIS J KEVIN | Sr.VP &Chief Financial Officer | 4,235 0.0077% | $105.58 | $447,131 | -4.36% | |
2022-06-01 | Sale | WILLIS J KEVIN | Sr.VP &Chief Financial Officer | 2,374 0.0044% | $105.58 | $250,647 | -2.08% | |
2022-05-17 | Sandler Ricky C | See Remarks | 48,800 0.0901% | $101.27 | $4.94M | +2.28% | ||
2022-05-17 | EMINENCE CAPITAL, LP | 48,800 0.0901% | $101.27 | $4.94M | +2.28% | |||
2021-09-10 | Sale | WILLIS J KEVIN | Chief Financial Officer | 2,208 0.0039% | $94.30 | $208,214 | +8.89% |
NOVO GUILLERMO | Chair of the Board and CEO | 31294 0.0663% | $1.62M | 2 | 0 | <0.0001% |
Assis Alessandra Faccin | SVP and GM, Life Sciences | 3150 0.0067% | $163,233.00 | 1 | 0 | |
EMINENCE CAPITAL, LP | 4083978 8.6556% | $211.63M | 2 | 1 | +0.91% | |
Sandler Ricky C | See Remarks | 4083978 8.6556% | $211.63M | 2 | 2 | +0.91% |
KALYANA SWAMINATHAN ASHOK | Sr VP & Gen Mgr, Life Sciences | 100 0.0002% | $5,182.00 | 1 | 0 | +14.77% |
Increased Positions | 180 | +42.76% | 5M | +10.4% |
Decreased Positions | 182 | -43.23% | 4M | -9.79% |
New Positions | 55 | New | 1M | New |
Sold Out Positions | 59 | Sold Out | 1M | Sold Out |
Total Postitions | 419 | -0.48% | 45M | +0.61% |
Vanguard Group Inc | $248,812.00 | 10.49% | 4.93M | +66,530 | +1.37% | 2024-12-31 |
Blackrock, Inc. | $242,817.00 | 10.23% | 4.81M | +325,623 | +7.26% | 2024-12-31 |
Eminence Capital, Lp | $144,397.00 | 6.09% | 2.86M | +212,916 | +8.04% | 2024-12-31 |
Dimensional Fund Advisors Lp | $142,288.00 | 6% | 2.82M | +44,018 | +1.59% | 2024-12-31 |
Massachusetts Financial Services Co /Ma/ | $141,693.00 | 5.97% | 2.81M | +208,320 | +8.02% | 2024-12-31 |
Allspring Global Investments Holdings, Llc | $86,897.00 | 3.66% | 1.72M | -16,321 | -0.94% | 2024-12-31 |
Diamond Hill Capital Management Inc | $79,143.00 | 3.34% | 1.57M | -358,191 | -18.6% | 2024-12-31 |
State Street Corp | $78,838.00 | 3.32% | 1.56M | +46,196 | +3.05% | 2024-12-31 |
Omega Advisors Inc. | $73,371.00 | 3.09% | 1.45M | +363,465 | +33.34% | 2024-12-31 |
Clearbridge Investments, Llc | $71,047.00 | 3% | 1.41M | -257,637 | -15.47% | 2024-12-31 |